No abstract available
Publication types
-
Case Reports
-
Letter
-
Comment
MeSH terms
-
Antipsychotic Agents / pharmacokinetics
-
Antipsychotic Agents / therapeutic use
-
Antipsychotic Agents / toxicity*
-
Ciprofloxacin / pharmacokinetics
-
Ciprofloxacin / therapeutic use
-
Ciprofloxacin / toxicity*
-
Clozapine / pharmacokinetics
-
Clozapine / therapeutic use
-
Clozapine / toxicity*
-
Cytochrome P-450 CYP1A2 / biosynthesis
-
Cytochrome P-450 CYP1A2 Inhibitors
-
Cytochrome P-450 CYP3A / biosynthesis
-
Cytochrome P-450 CYP3A Inhibitors
-
Drug Interactions
-
Enzyme Induction / drug effects
-
Humans
-
Inactivation, Metabolic
-
Male
-
Middle Aged
-
Myocarditis / blood
-
Myocarditis / chemically induced
-
Myocarditis / diagnosis
-
Psychotic Disorders / blood
-
Psychotic Disorders / drug therapy*
-
Psychotic Disorders / psychology
-
Risk Factors
-
Smoking Cessation*
-
Substance Withdrawal Syndrome / blood
-
Substance Withdrawal Syndrome / diagnosis*
-
Substance Withdrawal Syndrome / psychology
-
Urinary Tract Infections / blood
-
Urinary Tract Infections / drug therapy*
Substances
-
Antipsychotic Agents
-
Cytochrome P-450 CYP1A2 Inhibitors
-
Cytochrome P-450 CYP3A Inhibitors
-
Ciprofloxacin
-
Cytochrome P-450 CYP1A2
-
Cytochrome P-450 CYP3A
-
CYP3A4 protein, human
-
Clozapine